skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: Free E-Journal (出版社公開部分のみ） remover assunto: Male remover Leukemia remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease

Zamagni, E ; Nanni, C ; Gay, F ; Pezzi, A ; Patriarca, F ; Bellò, M ; Rambaldi, I ; Tacchetti, P ; Hillengass, J ; Gamberi, B ; Pantani, L ; Magarotto, V ; Versari, A ; Offidani, M ; Zannetti, B ; Carobolante, F ; Balma, M ; Musto, P ; Rensi, M ; Mancuso, K ; Dimitrakopoulou-Strauss, A ; Chauviè, S ; Rocchi, S ; Fard, N ; Marzocchi, G ; Storto, G ; Ghedini, P ; Palumbo, A ; Fanti, S ; Cavo, M

Leukemia, 2016-02, Vol.30 (2), p.417-422 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups

Bolli, Niccolo ; Biancon, Giulia ; Moarii, Matahi ; Gimondi, Silvia ; Li, Yilong ; de Philippis, Chiara ; Maura, Francesco ; Sathiaseelan, Vijitha ; Tai, Yu-Tzu ; Mudie, Laura ; O'Meara, Sarah ; Raine, Keiran ; Teague, Jon W ; Butler, Adam P ; Carniti, Cristiana ; Gerstung, Moritz ; Bagratuni, Tina ; Kastritis, Efstathios ; Dimopoulos, Meletios ; Corradini, Paolo ; Anderson, Kenneth C ; Moreau, Philippe ; Minvielle, Stephane ; Campbell, Peter J ; Papaemmanuil, Elli ; Avet-Loiseau, Herve ; Munshi, Nikhil C

Leukemia, 2018-12, Vol.32 (12), p.2604-2616 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma

González-Calle, V ; Dávila, J ; Escalante, F ; de Coca, A G ; Aguilera, C ; López, R ; Bárez, A ; Alonso, J M ; Hernández, R ; Hernández, J M ; de la Fuente, P ; Puig, N ; Ocio, E M ; Gutiérrez, N C ; García-Sanz, R ; Mateos, M V

Leukemia, 2016-10, Vol.30 (10), p.2026-2031 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Bahlis, N J ; Corso, A ; Mugge, L-O ; Shen, Z-X ; Desjardins, P ; Stoppa, A-M ; Decaux, O ; de Revel, T ; Granell, M ; Marit, G ; Nahi, H ; Demuynck, H ; Huang, S-Y ; Basu, S ; Guthrie, T H ; Ervin-Haynes, A ; Marek, J ; Chen, G ; Facon, T

Leukemia, 2017-11, Vol.31 (11), p.2435-2442 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

Muchtar, Eli ; Gertz, Morie A ; Kourelis, Taxiarchis V ; Sidana, Surbhi ; Go, Ronald S ; Lacy, Martha Q ; Buadi, Francis K ; Dingli, David ; Hayman, Suzanne R ; Kapoor, Prashant ; Leung, Nelson ; Fonder, Amie ; Hobbs, Miriam ; Lisa Hwa, Yi ; Gonsalves, Wilson ; Warsame, Rahma ; Russell, Stephen ; Lust, John A ; Lin, Yi ; Zeldenrust, Steven ; Rajkumar, S Vincent ; Kyle, Robert A ; Kumar, Shaji K ; Dispenzieri, Angela

Leukemia, 2020-04, Vol.34 (4), p.1135-1143 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial

Rosiñol, L ; Oriol, A ; Teruel, A I ; de la Guía, A L ; Blanchard, MaJ ; de la Rubia, J ; Granell, M ; Sampol, MaA ; Palomera, L ; González, Y ; Etxebeste, MaA ; Martínez-Martínez, R ; Hernández, M T ; de Arriba, F ; Alegre, A ; Cibeira, MaT ; Mateos, MaV ; Martínez-López, J ; Lahuerta, J J ; San Miguel, J ; Bladé, J

Leukemia, 2017-09, Vol.31 (9), p.1922-1927 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

Mai, Elias K ; Miah, Kaya ; Bertsch, Uta ; Dürig, Jan ; Scheid, Christof ; Weisel, Katja C ; Kunz, Christina ; Munder, Markus ; Lindemann, Hans-Walter ; Merz, Maximilian ; Hose, Dirk ; Jauch, Anna ; Seckinger, Anja ; Luntz, Steffen ; Sauer, Sandra ; Fuhrmann, Stephan ; Brossart, Peter ; Elmaagacli, Ahmet ; Goerner, Martin ; Bernhard, Helga ; Hoffmann, Martin ; Raab, Marc S ; Blau, Igor W ; Hänel, Mathias ; Benner, Axel ; Salwender, Hans J ; Goldschmidt, Hartmut

Leukemia, 2021-03, Vol.35 (3), p.809-822 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

KUMAR, S. K ; FLINN, I ; GROSMAN, D ; GLASS, J ; SAHOVIC, E. A ; SHI, H ; WEBB, I. J ; RICHARDSON, P. G ; RAJKUMAR, S. V ; NOGA, S. J ; HARI, P ; RIFKIN, R ; CALLANDER, N ; BHANDARI, M ; WOLF, J. L ; GASPARETTO, C ; KRISHNAN, A

Leukemia, 2010-07, Vol.24 (7), p.1350-1356 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome
Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

LOPEZ-VILLAR, O ; GARCIA, J. L ; HERNANDEZ-RIVAS, J. M ; SAN-MIGUEL, J. F ; DEL CAFNZO, M.-C ; SANCHEZ-GUIJO, F. M ; ROBLEDO, C ; VILLARON, E. M ; HERNANDEZ-CAMPO, P ; LOPEZ-HOLGADO, N ; DIEZ-CAMPELO, M ; BARBADO, M. V ; PEREZ-SIMON, J. A

Leukemia, 2009-04, Vol.23 (4), p.664-672 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation
CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation

PITTNER, B. T ; SHANAFELT, T. D ; KAY, N. E ; JELINEK, D. F

Leukemia, 2005-12, Vol.19 (12), p.2264-2272 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.